AIDX.TO stock closed after-hours at C$0.95, up 2.15% on 06 Mar 2026, as traders position ahead of an earnings release. Healwell AI Inc. (AIDX.TO) trades on the TSX with volume 815,520 versus an average of 554,603. The move reflects short-term momentum but also rising scrutiny of margins and cash flow ahead of the 2026-03-26 earnings announcement. We use public filings, sector data, and Meyka AI models to frame valuation, risks, and scenario price targets for investors tracking AI healthcare names.

AIDX.TO stock: Price, volume and trading context

Healwell AI Inc. (AIDX.TO) is trading C$0.95 after-hours, a C$0.02 intraday rise or +2.15% from the previous close of C$0.93. Volume today totaled 815,520 shares, above the 50-day average of 554,603, signaling elevated interest.

Market cap stands at C$264,477,880.00 with 278,397,768 shares outstanding. The 52-week range is C$0.58–C$1.81. Short-term trend indicators show momentum but rising overbought readings, so traders should expect volatility in after-hours and early session activity.

Business snapshot and AI healthcare positioning

Healwell AI Inc. develops AI decision-support tools for preventative care and clinical workflows. The company is headquartered in Toronto and operates in the healthcare technology segment on the TSX.

Strategic partnerships, including an alliance with WELL Health Technologies, underpin Healwell AI’s go-to-market strategy. These partnerships support pilot deployments, but commercial scale and recurring revenue remain key execution points for management and investors.

AIDX.TO stock financials and key ratios

Trailing metrics show EPS -0.23 and PE -4.13, reflecting current losses. Price-to-sales is 2.53, and price-to-book is 1.80. Cash per share is C$0.07 and book value per share is C$0.52.

Operating cash flow and free cash flow per share are negative at -0.10 and -0.11 respectively, and the current ratio is 0.85, below the healthcare sector average. These ratios highlight liquidity pressure if revenue growth does not accelerate.

AIDX.TO stock technicals and Meyka Grade

Technically, Healwell AI shows short-term strength: RSI 70.51 (overbought), ADX 37.49 (strong trend) and a 5‑day gain near 30.14%. Bollinger bands and CCI point to stretched momentum that could revert with weak earnings.

Meyka AI rates AIDX.TO with a score out of 100: 62.15 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. These grades are not guaranteed and we are not financial advisors.

Valuation, sector context and analysts view

Compared with the Canadian healthcare sector, Healwell AI’s price-to-sales 2.53 sits below some tech-enabled peers but its negative margins and low current ratio weigh on valuation. The sector’s YTD performance is mixed, with healthcare showing subdued returns versus other sectors.

No consensus external price target is widely published. Investors should weigh Healwell AI’s tech potential against weaker cash flow metrics and execution risk while comparing to broader healthcare and AI-health peers.

Catalysts, risks and upcoming earnings

Primary catalysts include the 2026-03-26 earnings release, new partnership announcements, and progress on recurring revenue traction. Positive surprises on revenue growth or margin improvement could re-rate the stock.

Key risks are continued negative operating cash flow, thin liquidity (current ratio 0.85), and sensitivity to execution in product commercialization. Regulatory and procurement cycles in healthcare may slow adoption and revenue realization.

Final Thoughts

Meyka AI’s forecast model projects a 12‑month price near C$0.40, implying -57.96% versus the current C$0.95. Scenario price targets: conservative C$0.60 (implied -36.84%), base C$1.20 (implied +26.32%), and bullish C$1.80 (implied +89.47%). These figures frame a wide outcome range driven by execution against the upcoming 2026-03-26 earnings report.

Short term, the stock shows momentum with above-average volume and overbought indicators. Medium term, investors should prioritize revenue growth, margin trends, and cash flow improvements. Use earnings as a decision point and size positions with attention to liquidity and volatility. Meyka AI provides this data as an AI-powered market analysis platform. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.